PT1206457E - Derivados de diaril-oxa(tia)zol e seu uso como moduladores dos ppars - Google Patents
Derivados de diaril-oxa(tia)zol e seu uso como moduladores dos pparsInfo
- Publication number
- PT1206457E PT1206457E PT00959401T PT00959401T PT1206457E PT 1206457 E PT1206457 E PT 1206457E PT 00959401 T PT00959401 T PT 00959401T PT 00959401 T PT00959401 T PT 00959401T PT 1206457 E PT1206457 E PT 1206457E
- Authority
- PT
- Portugal
- Prior art keywords
- diaril
- ppars
- zol
- tia
- oxa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15116299P | 1999-08-27 | 1999-08-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1206457E true PT1206457E (pt) | 2004-03-31 |
Family
ID=22537578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT00959401T PT1206457E (pt) | 1999-08-27 | 2000-08-23 | Derivados de diaril-oxa(tia)zol e seu uso como moduladores dos ppars |
Country Status (13)
Country | Link |
---|---|
US (3) | US6417212B1 (pt) |
EP (1) | EP1206457B1 (pt) |
JP (1) | JP2003508389A (pt) |
AR (1) | AR025386A1 (pt) |
AT (1) | ATE252091T1 (pt) |
AU (1) | AU7073400A (pt) |
CA (1) | CA2382966A1 (pt) |
DE (1) | DE60005973T2 (pt) |
DK (1) | DK1206457T3 (pt) |
ES (1) | ES2204684T3 (pt) |
PE (1) | PE20010529A1 (pt) |
PT (1) | PT1206457E (pt) |
WO (1) | WO2001016120A1 (pt) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7655699B1 (en) | 1992-04-22 | 2010-02-02 | Eisai Inc. | Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
WO1999005161A1 (en) | 1997-07-25 | 1999-02-04 | Ligand Pharmaceuticals Incorporated | HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR |
US7208522B1 (en) * | 2000-08-02 | 2007-04-24 | Pharmanutrients | Methods and compositions for the prevention and treatment of Syndrome X |
US6787552B2 (en) * | 2000-08-11 | 2004-09-07 | Nippon Chemiphar Co., Ltd. | PPAR delta activators |
AU2001284658A1 (en) * | 2000-08-23 | 2002-03-13 | Eli Lilly And Company | Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists |
WO2002016332A1 (en) * | 2000-08-23 | 2002-02-28 | Eli Lilly And Company | Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
JP2004506721A (ja) | 2000-08-23 | 2004-03-04 | イーライ・リリー・アンド・カンパニー | オキサゾリル−アリールプロピオン酸誘導体およびそのpparアゴニストとしての使用 |
GB0029974D0 (en) | 2000-12-08 | 2001-01-24 | Glaxo Group Ltd | Chemical compounds |
US7105551B2 (en) * | 2000-12-20 | 2006-09-12 | Smithkline Beecham Corporation | Thiazole derivatives for treating PPAR related disorders |
GB0031109D0 (en) * | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
EP1911462A3 (en) | 2001-01-26 | 2011-11-30 | Schering Corporation | Compositions comprising a sterol absorption inhibitor |
GB0113231D0 (en) * | 2001-05-31 | 2001-07-25 | Glaxo Group Ltd | Chemical compounds |
NZ529351A (en) * | 2001-06-07 | 2006-01-27 | Lilly Co Eli | Modulators of peroxisome proliferator activated receptors |
IL159002A0 (en) * | 2001-06-07 | 2004-05-12 | Lilly Co Eli | Modulators of peroxisome proliferator activated receptors (ppar) |
AR036237A1 (es) | 2001-07-27 | 2004-08-25 | Bayer Corp | Derivados del acido indan acetico, intermediarios, y metodo para su preparacion, composicion farmaceutica y el uso de dichos derivados para la manufactura de un medicamento |
US20110065129A1 (en) | 2001-07-27 | 2011-03-17 | Lowe Derek B | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
PT1424330E (pt) * | 2001-08-10 | 2011-12-22 | Nippon Chemiphar Co | Activador do receptor ä responsivo a proliferadores peroxissomais |
IL160845A0 (en) | 2001-09-14 | 2004-08-31 | Tularik Inc | Linked biaryl compounds |
GB0127916D0 (en) * | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
TW200303742A (en) * | 2001-11-21 | 2003-09-16 | Novartis Ag | Organic compounds |
KR20050044606A (ko) | 2001-11-30 | 2005-05-12 | 일라이 릴리 앤드 캄파니 | 퍼옥시솜 증식제에 의해 활성화된 수용체 아고니스트 |
WO2003072102A1 (en) | 2002-02-25 | 2003-09-04 | Eli Lilly And Company | Peroxisome proliferator activated receptor modulators |
US6833380B2 (en) | 2002-03-07 | 2004-12-21 | Warner-Lambert Company, Llc | Compounds that modulate PPAR activity and methods of preparation |
US6867224B2 (en) | 2002-03-07 | 2005-03-15 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods of preparation |
WO2003091211A1 (fr) * | 2002-03-28 | 2003-11-06 | Sumitomo Pharmaceuticals Co., Ltd. | Composes d'heteroaryle |
US6716842B2 (en) | 2002-04-05 | 2004-04-06 | Warner-Lambert Company, Llc | Antidiabetic agents |
US6875780B2 (en) * | 2002-04-05 | 2005-04-05 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods for their preparation |
UA79755C2 (en) * | 2002-04-16 | 2007-07-25 | Bayer Pharmaceuticals Corp | Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
CN1662487A (zh) | 2002-06-19 | 2005-08-31 | 伊莱利利公司 | 酰胺连接基过氧化物酶体增殖物激活受体调节剂 |
US7192970B2 (en) * | 2002-11-26 | 2007-03-20 | Chipscreen Biosciences, Ltd. | Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity |
US20060241157A1 (en) * | 2003-01-06 | 2006-10-26 | Conner Scott E | Heterocyclic ppar modulators |
WO2004066963A2 (en) * | 2003-01-17 | 2004-08-12 | Merck & Co., Inc. | N-cyclohexylaminocarbonyl benzenesulfonamide derivatives |
WO2004073606A2 (en) | 2003-02-14 | 2004-09-02 | Eli Lilly And Company | Sulfonamide derivatives as ppar modulators |
US20070105959A1 (en) * | 2003-03-11 | 2007-05-10 | Shinya Kusuda | Cynnamyl alcohol derivative compounds and drugs containing the compounds as active ingredient |
SE0301010D0 (sv) | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
SE0301009D0 (sv) * | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
US7244763B2 (en) | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
SA04250253B1 (ar) | 2003-08-21 | 2009-11-10 | استرازينيكا ايه بي | احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن |
NZ546031A (en) * | 2003-09-22 | 2009-03-31 | Ono Pharmaceutical Co | Phenylacetic acid derivative, process for producing the same, and use |
JP2007527416A (ja) * | 2003-10-31 | 2007-09-27 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ペルオキシソーム増殖因子活性化受容体(ppar)二重作動薬として有用なフェノキシ酢酸誘導体 |
EP1731513A4 (en) * | 2004-03-30 | 2007-10-31 | Daiichi Seiyaku Co | PHENOXYACETIC ACID DERIVATIVE AND MEDICAMENT CONTAINING THE SAME |
CN1946698B (zh) * | 2004-04-28 | 2010-12-01 | 霍夫曼-拉罗奇有限公司 | 作为ppar活化剂的吡唑苯基衍生物 |
CN100344618C (zh) * | 2004-05-24 | 2007-10-24 | 北京摩力克科技有限公司 | 作为hPPARα和hPPARγ激动剂的N-芳丙烯酰基取代的酪氨酸衍生物 |
WO2005115383A2 (en) * | 2004-05-25 | 2005-12-08 | Metabolex, Inc. | Substituted triazoles as modulators of ppar and methods of their preparation |
US20060014785A1 (en) * | 2004-05-25 | 2006-01-19 | Metabolex, Inc. | Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation |
GB0415320D0 (en) | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
FR2874378B1 (fr) * | 2004-08-17 | 2006-10-27 | Galderma Res & Dev | Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar et leur utilisation dans des compositions cosmetiques ou pharmaceutiques |
DE602005010444D1 (de) | 2004-08-17 | 2008-11-27 | Galderma Res & Dev | Neuartige biaromatische ppar-rezeptoren aktivierende zusammensetzungen und ihre verwendung in kosmetischen oder pharmazeutischen zusammensetzungen |
FR2874379B1 (fr) * | 2004-08-17 | 2006-10-27 | Galderma Res & Dev | Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar et leur utilisation dans des compositions cosmetiques ou pharmaceutiques |
CA2575029C (en) * | 2004-08-17 | 2013-11-12 | Galderma Research & Development, S.N.C. | Novel biaromatic compounds which activate receptors of ppar type and their use in cosmetic or pharmaceutical compositions |
GB0418830D0 (en) | 2004-08-24 | 2004-09-22 | Astrazeneca Ab | Novel compounds |
GB0422057D0 (en) * | 2004-10-05 | 2004-11-03 | Astrazeneca Ab | Novel compounds |
JP5208510B2 (ja) | 2004-11-23 | 2013-06-12 | アストラゼネカ・アクチエボラーグ | 呼吸器疾患の処置に有用なフェノキシ酢酸誘導体 |
TW200745003A (en) | 2005-10-06 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
EP1937632A1 (en) | 2005-10-06 | 2008-07-02 | Astra Zeneca AB | Novel compounds |
EP1948630A2 (en) * | 2005-11-05 | 2008-07-30 | AstraZeneca AB | Novel compounds |
WO2007068894A2 (en) * | 2005-12-15 | 2007-06-21 | Astrazeneca Ab | Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease |
US8023825B2 (en) * | 2006-04-04 | 2011-09-20 | Cisco Technology, Inc. | Optical switching architectures for nodes in WDM mesh and ring networks |
EP2014652B1 (en) | 2006-04-18 | 2014-08-06 | Nippon Chemiphar Co., Ltd. | Activating agent for peroxisome proliferator activated receptor |
JP4999923B2 (ja) * | 2006-06-13 | 2012-08-15 | 中国科学院上海薬物研究所 | 複素環非ヌクレオシド系化合物、抗ウィルス医薬組成物、及びウィルス性疾病治療薬物 |
UA100983C2 (ru) | 2007-07-05 | 2013-02-25 | Астразенека Аб | Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты |
RU2501794C2 (ru) | 2008-04-15 | 2013-12-20 | Ниппон Кемифар Ко., Лтд. | Активирующий агент для рецептора, активируемого стимулирующими рост пероксисом агентами |
JP2012506386A (ja) * | 2008-10-21 | 2012-03-15 | メタボレックス, インコーポレイテッド | アリールgpr120受容体アゴニストおよびその使用 |
WO2012027331A1 (en) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
MX2017008449A (es) | 2014-12-23 | 2017-10-12 | 4D Pharma Res Ltd | Polipeptido de pirina y modulacion inmune. |
CN113862175A (zh) | 2014-12-23 | 2021-12-31 | 4D制药研究有限公司 | 免疫调控 |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
CA2988695A1 (en) | 2015-06-15 | 2016-12-22 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
CN114984057A (zh) | 2015-06-15 | 2022-09-02 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
AU2016278067B2 (en) | 2015-06-15 | 2022-09-22 | Cj Bioscience, Inc. | Compositions comprising bacterial strains |
PT3209310T (pt) | 2015-11-20 | 2018-04-20 | 4D Pharma Res Ltd | Composições compreendendo estirpes bacterianas |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
CA3016179C (en) | 2016-03-04 | 2019-08-13 | 4D Pharma Plc | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
PL3630136T3 (pl) | 2017-05-22 | 2021-09-13 | 4D Pharma Research Limited | Kompozycje zawierające szczepy bakteryjne |
WO2018215782A1 (en) | 2017-05-24 | 2018-11-29 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
DK3600364T3 (da) | 2017-06-14 | 2020-08-31 | 4D Pharma Res Ltd | Sammensætninger omfattende en bakteriestamme af slægten megasphaera og anvendelser deraf |
WO2018229188A1 (en) | 2017-06-14 | 2018-12-20 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
US11498903B2 (en) | 2017-08-17 | 2022-11-15 | Bristol-Myers Squibb Company | 2-(1,1′-biphenyl)-1H-benzodimidazole derivatives and related compounds as apelin and APJ agonists for treating cardiovascular diseases |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
WO1993021166A1 (en) * | 1992-04-10 | 1993-10-28 | Smithkline Beecham Plc | Heterocyclic compounds and their use in the treatment of type ii-diabetes |
WO1994001420A1 (en) | 1992-07-03 | 1994-01-20 | Smithkline Beecham Plc | Heterocyclic compounds as pharmaceutical |
GB9225386D0 (en) | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
GB9326171D0 (en) | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
BR9508468A (pt) | 1994-07-29 | 1997-11-25 | Smithkline Beecham Plc | Composto processo para a preparação do mesmo composição farmacéutica processos para o tratamento e/ou profilaxia de hiperglicemia em um mamifero humano ou não humano e para o tratamento de hiperlípidemia hipertensão doença cardiovascular alguns distúrbios de alimentação o tratamento e/ou profilaxia de doença renal a prevenção revers o estabilização ou retardo da progressão de microalbuminuria em um mamifero humano ou não humano uso do composto e composto intermediário |
US5902726A (en) | 1994-12-23 | 1999-05-11 | Glaxo Wellcome Inc. | Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma |
US7115728B1 (en) | 1995-01-30 | 2006-10-03 | Ligand Pharmaceutical Incorporated | Human peroxisome proliferator activated receptor γ |
EP0815230A2 (en) | 1995-03-20 | 1998-01-07 | Ligand Pharmaceuticals, Inc. | MODULATORS OF ob GENE AND SCREENING METHODS THEREFOR |
US6022897A (en) * | 1995-04-25 | 2000-02-08 | The Salk Institute For Biological Studies | Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
JPH08325264A (ja) | 1995-05-31 | 1996-12-10 | Sumitomo Metal Ind Ltd | 新規2−芳香環置換−3−フェニルプロピオン酸またはアクリル酸誘導体 |
JPH08325250A (ja) | 1995-05-31 | 1996-12-10 | Sumitomo Metal Ind Ltd | 新規置換フェノール誘導体 |
US5939442A (en) * | 1995-06-07 | 1999-08-17 | The Salk Institute For Biological Studies | Modulations of peroxisome proliferator activated receptor-γ, and methods for the use thereof |
ES2216062T3 (es) * | 1995-09-18 | 2004-10-16 | Ligand Pharmaceuticals, Inc. | Tratamiento de la niddm con agonistas del rxr. |
GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
ES2202582T3 (es) * | 1996-02-02 | 2004-04-01 | MERCK & CO., INC. | Agentes antidiabeticos. |
GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
FR2749583B1 (fr) * | 1996-06-07 | 1998-08-21 | Lipha | Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant |
AU4050797A (en) * | 1996-08-02 | 1998-02-25 | Ligand Pharmaceuticals Incorporated | Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
WO1998007699A1 (fr) | 1996-08-19 | 1998-02-26 | Japan Tobacco Inc. | Derives d'acide propionique et applications de ces derives |
US6586455B1 (en) * | 1996-12-31 | 2003-07-01 | The Salk Institute For Biological Studies | Treatment of liposarcomas using a combination of thiazolidinediones and retinoid X receptor selective agonists |
US5814647A (en) * | 1997-03-04 | 1998-09-29 | Board Of Regents, The University Of Texas System | Use of troglitazone and related compounds for the treatment of the climacteric symptoms |
AU6773598A (en) * | 1997-03-26 | 1998-10-20 | Institut Pasteur | Treatment of gastrointestinal disease with ppar modulators |
EP1003777B1 (en) * | 1997-05-30 | 2007-01-24 | Dana Farber Cancer Institute | PGC-1, A NOVEL BROWN FAT PPARgamma COACTIVATOR |
US5925657A (en) * | 1997-06-18 | 1999-07-20 | The General Hospital Corporation | Use of PPARγ agonists for inhibition of inflammatory cytokine production |
WO1999005161A1 (en) * | 1997-07-25 | 1999-02-04 | Ligand Pharmaceuticals Incorporated | HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR |
BR9814087A (pt) * | 1997-10-17 | 2000-10-03 | Aventis Pharm Prod Inc | Processos para mediar a atividade do receptor de ppar-gama, e para tratar uma condição fisiológica em um paciente |
WO1999019313A1 (en) * | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
ES2252874T3 (es) * | 1997-12-12 | 2006-05-16 | Purdue Research Foundation | Utilizacion de acido linoleico conjugado para tratamiento de la diabetes mellitus tipo ii. |
IL136138A0 (en) * | 1997-12-19 | 2001-05-20 | Merck & Co Inc | Arylthiazolidinedione derivatives |
AU1887999A (en) * | 1998-01-29 | 1999-08-16 | Dr. Reddy's Research Foundation | Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
ATE451346T1 (de) * | 1998-03-10 | 2009-12-15 | Ono Pharmaceutical Co | Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten |
GB2335597A (en) | 1998-03-27 | 1999-09-29 | Glaxo Group Ltd | Stereoisomers of Troglitazone in the Treatment of Diabetes |
WO1999051740A2 (en) * | 1998-04-06 | 1999-10-14 | Janssen Pharmaceutica N.V. | Nucleotide sequence expressing human fatty acid transport protein and corresponding aminoacid, use for the regulation of fatty acids metabolism |
DE69919156T2 (de) * | 1998-05-11 | 2005-11-03 | Takeda Pharmaceutical Co. Ltd. | Oxyiminoalkansäure derivate mit hypoglykämischer und hypolipidemischer wirkung |
US6541669B1 (en) * | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
MA26662A1 (fr) * | 1998-07-21 | 2004-12-20 | Smithkline Beecham Plc | Derives de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation |
AP2001002036A0 (en) * | 1998-07-21 | 2001-03-31 | Smithkline Beecham Plc | Use of glucose uptake enhancer for reducing apoptosis. |
GB9817118D0 (en) * | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
-
2000
- 2000-08-23 PT PT00959401T patent/PT1206457E/pt unknown
- 2000-08-23 EP EP00959401A patent/EP1206457B1/en not_active Expired - Lifetime
- 2000-08-23 WO PCT/US2000/023358 patent/WO2001016120A1/en active IP Right Grant
- 2000-08-23 DE DE60005973T patent/DE60005973T2/de not_active Expired - Lifetime
- 2000-08-23 AT AT00959401T patent/ATE252091T1/de not_active IP Right Cessation
- 2000-08-23 JP JP2001519687A patent/JP2003508389A/ja not_active Withdrawn
- 2000-08-23 CA CA002382966A patent/CA2382966A1/en not_active Abandoned
- 2000-08-23 AU AU70734/00A patent/AU7073400A/en not_active Abandoned
- 2000-08-23 DK DK00959401T patent/DK1206457T3/da active
- 2000-08-23 ES ES00959401T patent/ES2204684T3/es not_active Expired - Lifetime
- 2000-08-23 US US09/644,457 patent/US6417212B1/en not_active Expired - Fee Related
- 2000-08-25 AR ARP000104410A patent/AR025386A1/es unknown
- 2000-08-25 PE PE2000000876A patent/PE20010529A1/es not_active Application Discontinuation
-
2002
- 2002-04-11 US US10/121,373 patent/US6610696B2/en not_active Expired - Fee Related
-
2003
- 2003-05-07 US US10/434,425 patent/US6825222B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1206457B1 (en) | 2003-10-15 |
AU7073400A (en) | 2001-03-26 |
AR025386A1 (es) | 2002-11-27 |
US20030045558A1 (en) | 2003-03-06 |
US6417212B1 (en) | 2002-07-09 |
CA2382966A1 (en) | 2001-03-08 |
ATE252091T1 (de) | 2003-11-15 |
ES2204684T3 (es) | 2004-05-01 |
US20040019090A1 (en) | 2004-01-29 |
PE20010529A1 (es) | 2001-05-18 |
DE60005973D1 (de) | 2003-11-20 |
WO2001016120A1 (en) | 2001-03-08 |
US6610696B2 (en) | 2003-08-26 |
DK1206457T3 (da) | 2004-02-16 |
WO2001016120A9 (en) | 2002-07-11 |
US6825222B2 (en) | 2004-11-30 |
JP2003508389A (ja) | 2003-03-04 |
EP1206457A1 (en) | 2002-05-22 |
DE60005973T2 (de) | 2004-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1206457E (pt) | Derivados de diaril-oxa(tia)zol e seu uso como moduladores dos ppars | |
EE200200251A (et) | Uued N-asabitsükloamiidi derivaadid ja nende kasutamine | |
EE200200318A (et) | Bensasooli derivaadid ja nende kasutamine JNK modulaatoritena | |
DE60016730D1 (de) | Wegwerfwindel | |
DE60018509D1 (de) | Wegwerfwindel | |
DE60037479D1 (de) | Absorbierender Wegwerfartikel | |
DE60040308D1 (de) | Absorbierender Wegwerfartikel | |
NO20000631D0 (no) | Absorberende, opptrekkbar engangsbleie og inkontinensbeskyttelse | |
BR9708894A (pt) | Derivados de acilmercapto-triazolila e seu uso como microbicidas | |
EE200200341A (et) | Asendatud oksasolidinoonid ja nende kasutamine | |
BR9709107A (pt) | Derivados de tiocianato-triazolila e seu uso como microbicidas | |
DK1198453T5 (da) | N-(indolcarbonyl-)piperazinderivater | |
BR9709258A (pt) | Derivados de sulfonil-mercaptotriazolila e seu uso como microbicidas | |
BR9706129A (pt) | 3-Hidroxiprina-2-Carboxamidoésteres preparação deles e uso dos mesmos como substâncias farmacêuticas | |
DE60030399D1 (de) | Wegwerfwindel | |
DE60015742D1 (de) | Medizinische elektrodenleitung | |
DE60018495D1 (de) | Tamponeinführhilfe | |
BR9804792A (pt) | Compostos de 1-alquil-4-benzoil-5-hidroxipirazol e seu uso como herbicidas | |
DE60019848D1 (de) | Absorbierender Wegwerfartikel | |
AR028281A1 (es) | Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona | |
PT1183251E (pt) | Derivados de indolilpiperidina como agentes anti-histaminicos e anti-alergicos | |
DE60025453D1 (de) | Wegwerfwindel | |
ES1044448Y (es) | Auto-aplicador de vendaje | |
DE50009644D1 (de) | Heterocyclisch annellierte indenochromenderivate | |
DE60025251D1 (de) | Tamponapplikator |